Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent endemic coronavirus infection is associated with less-severe COVID-19
Manish Sagar, Katherine Reifler, Michael R. Rossi, et al.
Journal of Clinical Investigation (2020) Vol. 131, Iss. 1
Open Access | Times Cited: 318

Showing 26-50 of 318 citing articles:

Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study
Li Guo, Yeming Wang, Liang Kang, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 664-676
Open Access | Times Cited: 88
Lung-resident memory B cells protect against bacterial pneumonia
Kimberly A. Barker, Neelou Etesami, Anukul T. Shenoy, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 11
Open Access | Times Cited: 88
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies
Carlota Dobaño, Rebeca Santano, Alfons Jiménez, et al.
Translational research (2021) Vol. 232, pp. 60-74
Open Access | Times Cited: 87
Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response
Chun-Yang Lin, Joshua Wolf, David C. Brice, et al.
Cell Host & Microbe (2021) Vol. 30, Iss. 1, pp. 83-96.e4
Open Access | Times Cited: 86
Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses
Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 10
Open Access | Times Cited: 82
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
William R. Morgenlander, Stephanie Henson, Daniel R. Monaco, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 7
Open Access | Times Cited: 81
Evolution of SARS-CoV-2: Review of Mutations, Role of the Host Immune System
Hélène Banoun
˜The œNephron journals/Nephron journals (2021) Vol. 145, Iss. 4, pp. 392-403
Open Access | Times Cited: 80
Identification of resident memory CD8 + T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue
Julia Niessl, Takuya Sekine, Joshua Lange, et al.
Science Immunology (2021) Vol. 6, Iss. 64
Open Access | Times Cited: 80
Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers
Ricardo da Silva Antunes, Suresh Pallikkuth, Erin Williams, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 1, pp. 70-80
Open Access | Times Cited: 79
COVID-19—Lessons Learned and Questions Remaining
Ferric C. Fang, Constance A. Benson, Carlos del Rı́o, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 12, pp. 2225-2240
Open Access | Times Cited: 76
Why Does the Severity of COVID-19 Differ With Age?
Petra Zimmermann, Nigel Curtis
The Pediatric Infectious Disease Journal (2021) Vol. 41, Iss. 2, pp. e36-e45
Open Access | Times Cited: 76
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role
Antonio Bertoletti, Anthony T. Tan, Nina Le Bert
Oxford Open Immunology (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 74
T cell immunity to SARS-CoV-2
Julia Niessl, Takuya Sekine, Marcus Buggert
Seminars in Immunology (2021) Vol. 55, pp. 101505-101505
Open Access | Times Cited: 71
COVID-19 Mechanisms in the Human Body—What We Know So Far
Ashutosh Kumar, Ravi Kant Narayan, Pranav Prasoon, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 64
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Marloes Grobben, Karlijn van der Straten, Philip J. M. Brouwer, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 63
Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients
Kerri Hagemann, Kristoffer Riecken, Johannes M. Jung, et al.
European Journal of Immunology (2022) Vol. 52, Iss. 8, pp. 1297-1307
Open Access | Times Cited: 60
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines
Joey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 11, pp. 100793-100793
Open Access | Times Cited: 54
Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
Deepta Bhattacharya
Immunity (2022) Vol. 55, Iss. 6, pp. 945-964
Open Access | Times Cited: 47
The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
Esther Moga, Elionor Lynton-Pons, Peré Domingo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
Andrew R. Crowley, Harini Natarajan, Andrew P. Hederman, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 43
COVID‐19 and plasma cells: Is there long‐lived protection?*
Doan C. Nguyen, Pedro A. Lamothe, Matthew C. Woodruff, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 40-63
Open Access | Times Cited: 41
Immune imprinting and next-generation coronavirus vaccines
Chloe Qingzhou Huang, Sneha Vishwanath, George Carnell, et al.
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 1971-1985
Closed Access | Times Cited: 38
The past, current and future epidemiological dynamic of SARS-CoV-2
François Balloux, Cedric C.S. Tan, Leo Swadling, et al.
Oxford Open Immunology (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 37
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
Laura Pérez‐Alós, Cecilie Bo Hansen, José Juan Almagro Armenteros, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30

Scroll to top